Biotechgate Global Database ›
News in the Life Sciences Industry | |
| Results 1 - 6 out of 6 displayed. | |
Qu Biologics Completes Enrollment in First Stage of Phase 2 Clinical Trial in Moderate to Severe Crohn’s Disease |
| Read more ›› |
| By: GlobenewsWire - 18 Dec 2019 |
Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China |
SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology... Read more ›› |
| By: PR Newswire Association LLC. - 04 Dec 2019 |
Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China |
SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK).... Read more ›› |
| By: PR Newswire Association LLC. - 04 Dec 2019 |
EB Research Partnership Announces New $3 Million Gift from the Ann & Ari Deshe Family |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 07 Nov 2019 |
GHIT Fund Announces New Investments: A Total of 630 Million Yen in Drugs for Malaria, Tuberculosis, Chagas Disease and Leishmaniasis, Vaccines for Malaria and Chagas Disease, and Diagnostics for Malaria |
TOKYO, Sept. 30, 2019 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of 630 million yen (US$5.9 million*) to invest in eight partnerships to develop new lifesaving drugs, vaccines and diagnostics for malaria, tuberculosis, Chagas disease and leishmaniasis.... Read more ›› |
| By: PR Newswire Association LLC. - 30 Sep 2019 |
Ardigen Was Accepted Into the Prestigious TESLA Consortium Working to Improve Personalization of Immunotherapies |
KRAKÓW, Poland, Sept. 3, 2019 /PRNewswire/ -- We are proud to announce that Ardigen was accepted into the international Tumour neoantigEn SeLection Alliance (TESLA). The consortium was founded by the Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI). TESLA is... Read more ›› |
| By: PR Newswire Association LLC. - 03 Sep 2019 |
| Related companies: Ardigen S.A. |
Partners
Upcoming Life Sciences Events
- February 2020
- Allschwil: Fundraising Bootcamp
- Amsterdam: Pharma & Biotech Patent Litigation
- March 2020
- : Evolution Summit
